Therapeutic Efficacy of Chloroquine for the  Treatment of Uncomplicated Plasmodium Vivax Infection in Shewa Robit Health Center, North  East Ethiopia

Habtamu, Belay

dc.contributor.author	Habtamu, Belay
dc.date.accessioned	2022-03-29T05:27:26Z
dc.date.available	2022-03-29T05:27:26Z
dc.date.issued	2022-03-27
dc.identifier.uri	http://ir.bdu.edu.et/handle/123456789/13367
dc.description.abstract	Background: Malaria remains the most prevalent and fatal vector-borne disease in the world. In Ethiopia, two-thirds of the population lives in areas at risk of malaria infection. The development of drug resistance to available antimalarial drugs is the main challenge in the prevention and control of malaria in all endemic areas. Chloroquine is the first-line treatment for uncomplicated P.vivax in Ethiopia. The emergence of P.vivax resistance to chloroquine in the country threatens the efficacy of P.vivax treatment.	en_US
dc.language.iso	en	en_US
dc.subject	Plasmodium vivax, Therapeutic efficacy, Shewa Robit, Ethiopia	en_US
dc.title	Therapeutic Efficacy of Chloroquine for the Treatment of Uncomplicated Plasmodium Vivax Infection in Shewa Robit Health Center, North East Ethiopia	en_US
dc.type	Thesis	en_US